Literature DB >> 29399786

Novel NALCN biallelic truncating mutations in siblings with IHPRF1 syndrome.

A Angius1, S Cossu2, P Uva3, M Oppo1,4, S Onano1,4, I Persico1, G Fotia3, R Atzeni3, G Cuccuru3, M Asunis5, F Cucca1,4, D Pruna5, L Crisponi1,4.   

Abstract

Infantile hypotonia with psychomotor retardation and characteristic facies-1 (IHPRF1) is a severe autosomal recessive neurologic disorder with onset at birth or in early infancy. It is caused by mutations in the NALCN gene that encodes a voltage-independent, cation channel permeable to NM, K+ and Ca2+ and forms a channel complex with UNCSO and UNC79. So far, only 4 homozygous mutations have been found in 11 cases belonging to 4 independent consanguineous families. We studied a Sardinian family with 2 siblings presenting dysmorphic facies, hypotonia, psychomotor retardation, epilepsy, absent speech, sleep disturbance, hyperkinetic movement disorder, cachexia and chronic constipation. Polymorphic generalized seizures started at 4 and 6 years, respectively. Anti-epileptic drugs (AEDs) therapy was efficient for female proband's epilepsy, but the male still has weekly seizures. Whole exome sequencing identified 2 novel truncating mutations in NALCN allowing to assess the clinical phenotype to IHPRF1. This is the fifth family reported worldwide, and these are the first European cases with IHPRF1 syndrome with biallelic truncating mutations of NALCN.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29399786     DOI: 10.1111/cge.13162

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease.

Authors:  Merve Kasap; Donard S Dwyer
Journal:  J Neural Transm (Vienna)       Date:  2021-05-07       Impact factor: 3.575

2.  NGS-driven molecular diagnosis of heterogeneous hereditary neurological disorders reveals novel and known variants in disease-causing genes.

Authors:  Ayaz Khan; Shixiong Tian; Muhammad Tariq; Sheraz Khan; Muhammad Safeer; Naimat Ullah; Nazia Akbar; Iram Javed; Mahnoor Asif; Ilyas Ahmad; Shahid Ullah; Humayoon Shafique Satti; Raees Khan; Muhammad Naeem; Mahwish Ali; John Rendu; Julien Fauré; Klaus Dieterich; Xenia Latypova; Shahid Mahmood Baig; Naveed Altaf Malik; Feng Zhang; Tahir Naeem Khan; Chunyu Liu
Journal:  Mol Genet Genomics       Date:  2022-08-24       Impact factor: 2.980

3.  Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).

Authors:  Nuria C Bramswig; Aida M Bertoli-Avella; Beate Albrecht; Aida I Al Aqeel; Amal Alhashem; Nouriya Al-Sannaa; Maissa Bah; Katharina Bröhl; Christel Depienne; Nathalie Dorison; Diane Doummar; Nadja Ehmke; Hasnaa M Elbendary; Svetlana Gorokhova; Delphine Héron; Denise Horn; Kiely James; Boris Keren; Alma Kuechler; Samira Ismail; Mahmoud Y Issa; Isabelle Marey; Michèle Mayer; Jennifer McEvoy-Venneri; Andre Megarbane; Cyril Mignot; Sarar Mohamed; Caroline Nava; Nicole Philip; Cecile Ravix; Arndt Rolfs; Abdelrahim Abdrabou Sadek; Lara Segebrecht; Valentina Stanley; Camille Trautman; Stephanie Valence; Laurent Villard; Thomas Wieland; Hartmut Engels; Tim M Strom; Maha S Zaki; Joseph G Gleeson; Hermann-Josef Lüdecke; Peter Bauer; Dagmar Wieczorek
Journal:  Hum Genet       Date:  2018-08-23       Impact factor: 4.132

4.  Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex.

Authors:  Jinhong Wie; Apoorva Bharthur; Morgan Wolfgang; Vinodh Narayanan; Keri Ramsey; Kimberly Aranda; Qi Zhang; Yandong Zhou; Dejian Ren
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

5.  A Homozygous Truncating Mutation in NALCN Causing IHPRF1: Detailed Clinical Manifestations and a Review of Literature.

Authors:  Amir Hossein Karimi; Mohammad Reza Karimi; Poopak Farnia; Farshid Parvini; Majid Foroutan
Journal:  Appl Clin Genet       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.